FDA issued a not-approvable letter to Wright Medical Technology Inc. for its Augment bone graft, the company announced August 8. Wright is seeking PMA approval for Augment as an alternative to autograft in hindfoot and ankle fusion procedures.
FDA says that the clinical data Wright submitted was mostly from low-risk patients who “may not have warranted the use of either autograft or Augment Bone Graft.” To earn approval,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?